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Abstract 
  Here, we introduce core-shell nanofibers based on chitosan (CS)-loaded poly (ε-
caprolactone) (PCL) shell and 5-fluorouracil (5-FU)-loaded Poly(N-vinyl-2-
pyrrolidone) (PVP) core for synergistic therapy of melanoma skin cancer. The yielded 
nanofibers exhibited an average diameter of 503 nm with high drug-encapsulating 
efficiency and good mechanical properties. Moreover, the burst release of 5-FU 
significantly inhibited melanoma skin cancer cells (B16F10 cells), and the sustained 
release of CS exhibited “remedying effects” on normal skin cells (L929 cells) after 
suffering adverse effects from 5-FU treatment. For the B16F10 cells, the early apoptosis 
cells increased from 0. 8% to 62.2% after being treated with blended films loaded with 
5-FU (2 wt%) for 24 h; for the L929 cells, the vital cells increased from 68.9% to 77.0%, 
and the early apoptosis of stage cells decreased from 12.3% to 10.9% after being treated 
with blended films with CS (8 wt%) for 24 h. In conclusion, the results introduced in 
this work can be a promising strategy for cancer treatment and possesses synergism 
potential to broaden an avenue for chemotherapeutic therapy with minimum adverse 
effects on normal cells.  
 
Keywords: skin cancer; chitosan; 5-fluorouracil; core-shell nanofiber; controlled 
release. 
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1. Introduction 
  Skin cancer is one of the most common and aggressive neoplasms with cutaneous 
melanoma being responsible for approximately 75% of all deaths induced by skin 
cancer (Esteva et al., 2017). The incidence of this melanoma is increasing especially in 
Western countries (Gray-Schopfer et al., 2007). Some factors in daily life will induce 
the incidence of melanoma, such as overdose of ultraviolet (UV) radiation, alcohol 
consumption as well as family history, immune suppression and gene polymorphisms 
(Sabitha et al., 2013). Although various treatments of melanoma are developed, such as 
chemotherapy, surgical resection, and immunotherapy, the cure rate still needs to be 
improved further (Ma et al., 2017). To inhibit the cancer cell growth and aggressiveness, 
5-Fluorouracial (5-FU) is one of the common agents used in chemotherapy due to 
effective inhibition and extermination effects against skin cancer (Longley et al., 2003). 
5-FU works by inhibiting thymidylate synthase and incorporation of its metabolites 
(fluoronucletides) into RNA and DNA (Longley et al., 2003). 5-FU is conventionally 
applied in solutions at the various concentration (1%, 2%, and 5%) or creams (0.5%, 
1%, and 5%) (Khan et al., 2015).  
Transdermal delivery of drugs has been suffered by poor penetration in the deeper 
skin layers due to the poor penetration concerning the transdermal drug delivery (Lee 
et al., 2016). Various approaches have been developed to overcome the stratum 
corneum barrier and improve drug accumulation at the targeting area. For example, 
using microneedles (Prausnitz and Langer, 2008) or nanoparticles (Wang et al., 2011) 
as drug carriers can aid drug penetration into the deeper layers of the skin compared to 
more conventional drug deliveries (e.g. solutions, creams). Another approach to aid this 
is to improve the therapeutic effect by controlling the drug release period. By using 
solid-lipid nanoparticles (Shah et al., 2011) and core-shell nanofibers (Chen et al., 2015) 
and encapsulating drugs into the lipid matrix or into the core, it is possible to control 
drug release rate via altering the solid-to-lipid or core-to-shell ratio. There is research 
that has shown significant anti-proliferative effects against +SA mammary epithelial 
cells at low concentrations (0.52±0.02 µM) (Ali et al., 2010). Despite this, the adverse 
effects of 5-FU on normal health cells (e.g. hair loss, liver disorders) should not be 
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neglected (Rezaei et al., 2018). Hence, extra recovery therapy following 5-FU treatment 
to minimize long term side-effects and impairment of normal heath tissue cells around 
the targeting is critical on synergism skin cancer treatments. 
Nano-scaled core-shell ultrafine fibers (combining excellent properties of two 
components) can incorporate bioactives within the core-shell structure and provide 
improved advantages regarding biocompatibility, super-hydrophobicity, and 
mechanical properties (Chen et al., 2015). Moreover, large proportion of dual drugs can 
be efficiently co-encapsulated in single-step preparation attributing to high surface-
area-to-volume ratio (Jia et al., 2017). As a result, nanofibers with core-shell structures 
have demonstrated excellent property with respect to encapsulating two agents in 
separate regions of the same carrier simultaneously, exhibiting enhanced therapeutic 
effects (Kamel et al., 2017; Seyednejad et al., 2012). Coaxial electrospinning (CO-ES), 
composing of two or more concentric nozzles, has shown efficiency and versatility in 
the fabrication of core-shell fibers (Sun et al., 2003). Driven by a high-voltage 
electrostatic field combined with a gravitational field, CO-ES has been used to fabricate 
micro- and nano-complex structures on-demand in a one-step process (Forward et al., 
2013; Zhou et al., 2012). Due to its versatility and not requiring harsh processing 
conditions (e.g. high temperatures), it overcomes the limitations seen with more 
conventional methods such as hot-melt extrusion and single-nozzle ES (Jia et al., 2017).  
In addition to this, some novel and multi-functional properties, such as controlled drug 
release, functionalized fiber surface (Sun et al., 2006) and targeted drug delivery (Jia et 
al., 2017) have been demonstrated via CO-ES technique.  
  Chitosan (CS) is a derivative yielded following deacetylation of chitin. During this 
process, the N-acetyl-D-glucosamine (GlcNAc) unit in chitin is converted to D-
glucosamine (GlcN) unit, forming chitosan (Cho et al., 2000). Due to its 
biocompatibility, non-toxicity, and biodegradability (Kurita, 2006), chitosan has been 
used as a key material for drug delivery (Dev et al., 2010) and in healthcare engineering 
(Ragetly et al., 2010). Moreover, the significant improvement of fibroblast cells (L929 
cells) proliferation has been revealed (Zhu et al., 2019). However, its inherent poor 
solubility and polycationic character limits the electro-spinnability of chitosan. This 
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can be improved by blending with other polymers such as polylactic acid (PLA) and 
polyvinyl alcohol (PVA) (Chen et al., 2015).  
  Poly (ε-caprolactone) (PCL) has also gained increasing interest in drug delivery, 
surgery sutures, and fibrous scaffolds due to its biodegradability and excellent 
biocompatibility (Ruckh et al., 2010). Poly(N-vinyl-2-pyrrolidone) (PVP) has 
conventionally been used as a filler component and has previously been blended with 
other polymers. It is widely used for its biocompatibility and its solubility in water and 
most organic solvents (Kim et al., 2013). It was found that after being blended with 
PVP, the diffusion of water into the PCL chains was improved and the hydrolytic 
degradation of blending mixture was accelerated (García Cruz et al., 2009; Yu et al., 
2006). 
  In the present study, blending nanofibers of PCL/PVP with core-shell structure was 
fabricated via CO-ES. The PCL/chitosan was used as shell layer, and PVP 
(encapsulating 5-FU) was used as the core layer. PCL/PVP nanofibers were studied 
using imaging (SEM), spectroscopy (FT-IR) and X-ray diffraction (XRD). In vitro drug 
release results indicated the burst release of 5-FU first inhibited the cutaneous 
melanoma cell proliferation and the subsequent sustained release of chitosan protected 
the normal cell from the accidental injury of 5-FU. Thus, synergetic cancer treatments 
by minimizing the negative effects of 5-FU on normal cells and inhibiting the skin 
cancer cells growth is demonstrated in the work presented here. 
 
2. Materials and methods 
2.1. Materials  
PCL (Mw = 8×104 g/moL), PVP ( Mw = 1.3×106 g/moL) were purchased from 
Sigma-Aldrich (St Louis, USA). CS (degree of deacetylation = 81 %, Mw = 8908 
g/moL) was prepared according to previous work (Zhu et al., 2019). 5-FU was 
purchased from Solarbio (Solarbio Science & Technology Co., Ltd., Beijing, China). 
Ethanol (100%), Dimethylsulfoxide (DMSO), and acetic acid were purchased from 
Sinopharm (Sinopharm Chemical Reagent Co., Ltd., Shanghai, China). Modified eagle 
medium (MEM), Dulbecco’s modified eagle medium (DMEM) was obtained from 
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Gibco (Gibco, Carlsbad, California, USA); and fetal bovine serum (FBS) was obtained 
from Sijiqin (Sijiqin, Hangzhou, China). Deionized water (DI) was obtained from 
ultrapure water purifier (Millipore Milli-Q, Bedford, USA). All chemicals and reagents 
of analytical grade.  
 
2.2. Preparation of electrospinning solutions 
PCL solution (18 wt%) was prepared by dissolving PCL in acetic acid while PVP 
solution (18 wt%) was prepared by dissolving PVP in ethanol. Chitosan at various 
concentrations was dissolved using 400 µL mixture solution of acetic acid and DI water 
(50: 50, v/v) as shown in Table 1. 5-FU was added in 250 µL DMSO to obtain 2 wt% 
(weight of PVP) solution. To form homogeneous polymer solutions, the initial mixtures 
were stirred (ca. 300 rpm) constantly for 8h at ambient temperature (24 ℃) using a 
magnetic stirrer (VELP ARE heating magnetic stirrer, Italy).  The chitosan solution 
and 5-FU solution were then added to the PCL solution and PVP solution, respectively, 
and were stirred for 1h before electrospinning. 
 
2.3. Fabrication of PCL-CS/PVP-5-FU nanofibers using CO-ES 
The CO-ES apparatus used in this work is shown in Fig. 1a. The set-up consists of a 
high power voltage supply (Glassman High Voltage Inc. series FC, USA), two syringe 
pumps (KD Scientific KDS100, USA), the inner and outer needles having 
internal/external diameters of 0.2/0.4 and 0.9/1.2 mm, respectively. The resulting PCL-
CS solution was loaded in a 5 mL syringe and perfused into the outer needle using a 
syringe pump with a flow rate of 0.6 ml/h while the PVP-5-FU solution was perfused 
into the inner needle with a flow rate of 0.2 ml/h. A grounded roller approximately 14 
cm long and 7 cm in diameter at rotating speed of ca. 650 rpm was used to collect the 
resulting spun fibers. To generate nanofibers, a high voltage (15.5 -17.5 kV) was 
applied between the coaxial needle and roller, and the distance between the roller and 
needle tip was ~ 10 cm vertically at ambient temperature (24 ℃). A series of fibers was 
prepared as detailed in Table 1.  
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2.4. Fiber morphology assessment 
The surface morphology of electrospun fibers was assessed via optical microscope 
(OM, phoenix BMC503-ICCF, China) and SEM (Quanta FEG650, FEI, Netherland). 
For SEM analysis, samples were coated with a layer of gold using a sputter-coater (108 
Auto Cressington Sputter Coater, Ted Pella, Inc.) for 60 s with the current intensity of 
25 mA. The SEM images of samples were obtained at an accelerating voltage of 20 kV. 
The mean fiber diameters and fiber size distribution were quantified using 100 random 
fibers using ImageJ software (National institute of Health, MD, USA).      
 
2.5. Fourier transform infrared (FT-IR) spectroscopy 
The composition and chemical interactions of the core-shell nanofibers were 
analyzed using FT-IR spectroscopy (IR Affinity 1, Shimadzu, Japan). Each sample (ca. 
2 mg) was mixed with KBr powder (ca. 200 mg) and compressed into transparent 
pellets using a powder compressing machine (FW-4A, Tianjin TUOPU instrument Co., 
Ltd, Tianjin, China) under pressure (ca. 20 MPa) for 2 min. The FT-IR spectra of each 
sample was acquired within the scanning range 4000–400 cm-1 and resolution of 4 cm-
1 at an average of 20 scans.  
 
2.6. X-Ray Diffraction (XRD) 
The crystal configuration of electrospun fibers was analyzed using an X-ray 
diffractometer (Gemini A OHra, Oxford Varian, UK) at 25 °C. The samples were 
examined under the following conditions: 1˚of DivSlit and 10 mm of DivH.L. Slit, 
continuous scanning at the 2θ range 3-60˚ with deploying step of 0.02˚ and step speed 
of 5˚/min. The analyzing voltage and current was 40 kV and 30 mA, respectively. 
 
2.7. Contact angle analysis 
The water contact angle (CA) of resulting films was measured using optical contact 
angle meter (SJ200KB, KINO Industry Co., Ltd., USA). The CA value of sample was 
obtained through sessile-drop mode at 25 °C. Briefly, a 1 µL water droplet was dropped 
on the film sample and recording the CA. The mean CA results were obtained using 
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three samples with triplicate measurements.  
 
2.8. Tensile test  
The mechanical strength of the resulting films was determined using a universal 
materials tester (Zwick/ Roell Z020, Zwick, Germany). Firstly, the films were shaped 
into dog-bone shaped matrices using standard shape (length × width = 7.5 cm×1.4 cm). 
The thickness of each sample was then measured using a coating thickness gauge (PD-
CT1, Powered Technology (Beijing) Co., Ltd). Selecting gauge of 10 mm in length and 
load cell of 500 N was used to carry out tensile testing with the crosshead speed of 10 
mm/min at 25 ℃. Each sample type was assessed in triplicate and the mean tensile 
strength was obtained. 
 
2.9. Release study in vitro 
The loading capacity (LC) and encapsulation efficiency (EE) of CS or 5-FU were 
used to evaluate the encapsulating effect of the electrospinning process. According to 
the methods showed in previous work (Yao et al., 2017) with slight modifications. LC 
and EE were calculated using Eq. (1) and Eq. (2), respectively. 
LC (%) =	"#$%&	%'#()$	#*	+,	#-	./01	2#)$3)$	4)	*453-6	('8)	:'#()$	#*	*453-6	('8)  ×100%  (1) 
EE (%) =	 "#$%&	%'#()$	#*	+,	#-	./01	2#)$3)$	4)	*453-6	('8)	"#$%&	%'#()$	#*	;<=	%>>3>	4)	?#&@'3-	6#&($4#)	('8) ×100%  (2) 
Where, the total amount of CS or 5-FU content encapsulated in fibers was measured 
using UV spectrophotometer (UV-2600 spectrophotometer, Shimadzu, Japan) at a 
wavelength of 201 nm (Liu et al., 2006) and 265 nm (Khan et al., 2015) respectively; 
and measured by the fitting equations (Fig. S1a & b) following fiber dissolution in 
acetic acid. 
The release of encapsulated CS or 5-FU from the engineered fibers was measured 
using phosphate buffer solution (PBS) with pH = 5.7 ± 0.1 to mimic melanoma cell 
micro-environment according to previous work (Sahu et al., 2017). Briefly, a sample of 
the films was immersed into a jar containing 10 mL PBS and was agitated using a Gas-
bathing Constant Temperature Vibrator (DDHZ-300, Suzhou Peiying experimental 
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equipment Co., Ltd, Suzhou, China) at 100 rpm, 37.5 ℃. At pre-determined time points, 
4.0 ml of the release medium was removed and replaced with 4.0 ml of fresh PBS. The 
concentration of released drug was obtained using the UV spectroscopy and fitting 
equations (Fig. S1a & b). The percentage of the released CS or 5-FU was calculated 
using Eq. (3) (Yao et al., 2017): 
Mass release (%)= mt/ms×100%                            (3) 
Where, mt was the weight of released agent (CS or 5-FU) at time point t, ms was 
the weight of agent (CS or 5-FU) encapsulated in the sample. 
 
2.10. Inhibitory effect on melanoma cell line 
L929 (mouse fibroblasts) and B16F10 (mouse melanoma cell) cells were used to 
evaluate the synergistic and anticancer effect of resulting fibers on normal and cancer 
cells, respectively. L929/B16F10 cells were cultured in MEM/DMEM supplemented 
with 10% FBS in culture dishes (Ф = 10 cm) at 37 ℃ in a humidified atmosphere of 5% 
CO2, and were grown to ca. 85% confluence prior to further treatment. 
The cell viability was measured using a CCK-8 kit (cell counting Kit-8 reagent, 
Dojindo Laboratories, Kumamoto, Japan). Here, cells (1.0 ×105 cells/mL) were seeded 
into 96-well plates and co-cultured with various concentration of 5-FU solution after 
being cultured for 24 h. The 5-FU was dissolved into DMSO and then diluted to various 
concentrations using MEM/DMEM for the L929/B16F10 cells. After treatment with 5-
FU for 48 h, the optical density (OD) was measured using a microplate reader (Spectra 
Max 190, NanoDrop, USA) at 450 nm after being incubated with 10 µL CCK-8 solution 
for 4 h. The cell viability was measured according to the CCK-8 kit manufacture 
instructions. 
The effects of the resulting fibers on the cell cycle and apoptosis of cells were 
analyzed using Flow Cytometry Analysis (FACScalibur, Becton Dickinson, USA). 
Before treatment, the fibers were disinfected using UV irradiation for 2h. Equal 
numbers of cells (2.0 ×105 cells) were co-cultured with resulting fibers (ca. 100 ± 2 mg) 
in culture dishes (Ф = 6 cm) at standard cultural environment. At the pre-determined 
time points, the cells were harvested and washed twice with PBS (pH7.4) and then 
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centrifuged at 1000 rpm for 5 mins. The cells were then stained with Annexin V-FITC 
and PI (Apoptosis Detection Kit, Multi Sciences, Hangzhou China) and Cell Cycle 
Staining kit (Apoptosis Detection Kit, Multi Sciences, China) to detect apoptosis and 
cell cycle of cells, respectively. 
To visualize the effects of fibers on apoptosis of cells a AO/EB dye mixture kit 
(Solarbio Life Science, Beijing, China) was used to evaluate the cell death mode. 
Briefly, cells suspension (1.2×105 cells) was seeded into a 6-well plate and incubated 
for 24 h. The fibers (ca. 100 ± 2 mg) were added into each well and co-cultured at 
standard cultural environment. At pre-determined time points, the cells were harvested 
via trypsinization and washed twice with PBC (pH 7.4) and were centrifuged at 
1000rpm for 5 mins. The cells were suspended in 500 µL PBS (pH 7.4) and were stained 
using 20 µL AO/ED dye mixture (AO: EB = 1:1 v/v) for 10 mins at 25°C. A sample 
(ca. 10 µL) of the stained cell suspension was observed using Fluorescence Microscopy 
(Olympus, BX61W1-FV1000, Tokyo, Japan). 
 
2.11. Statistical analysis  
Results were expressed as mean ± standard deviation (n=3). Comparison among 
treatment group was carried out via Student’s unpaired t-test (*p< 0.05, **p< 0.01). All 
of the statistical plots were plotted using Origin Software (OrginLab, USA). 
 
3. Results and discussion  
3.1. Morphology of electrospun nanofibers  
  The CO-ES process involves the main interaction between electrical field, solution 
surface tension and gravity (Gao et al., 2016). Polymer concentration is a crucial 
parameter which will determine the spinnability of the solution and the stability of ES 
process, respectively (Li and Wang, 2013). In this study, the blended fibers were 
prepared according to compositions shown in Table 1 and the effect of CS concentration 
(varied from 0- 8 wt%) on fibers’ morphology was explored. As shown in Fig. 1b, a 
stable typical Taylor-cone was observed at the optimum electrical potential (~ 17.5 kV, 
vi), which evolved from dripping mode (Fig. 1bi) at 0 kV to stretched mode at the 
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voltage range from 5 kV (Fig. 1bii) to 10.5 kV (Fig. 1biii), then to jetting mode in the 
range between 13.5 (Fig. 1iv) and 15.5 kV (Fig. 1v). The effect of CS concentration on 
fiber formation is shown in Fig. 2. The OM images (Fig. 2a1-e1) show ultrafine fibers 
obtained from polymer solutions with various CS concentrations, suggesting increasing 
the CS concentration results in more uniform fibers. Fig. 2a2-e2 show the SEM images 
and their high magnification of the engineered fibers with various morphology as a 
result of CS concentration. Bifurcate and sticking together fibers (Fig. 2a2 (F-1)) at low 
CS concentration were more obvious than other images (Fig. 2 b2-e2), and the more 
“embossments” showed in the inset images as the increasing of CS concentration.  
  The improvement of fiber surface morphology by using CS may be attributed to the 
fact that CS possesses a cationic polyelectrolytic property in acidic media; increasing 
the surface charges concentration of the jets (Sedghi and Shaabani, 2016). A stronger 
elongation force is then exerted on the ejecting jets during the electrospinning process 
resulting in smaller, thinner fibers. The effects of CS concentration on diameter of 
resulting fibers were evident. The distribution of diameter was more concentrated as 
the increasing of CS concentration. The mean diameter of F-5 decreased from 1594 ± 
946 nm to 769 ± 398 nm when increasing the CS concentration from 0 wt% to 8 wt%. 
In order to confirm the core-shell structure (F-5), following in vitro release studies the 
fibers were analyzed using SEM. Fig. 2f1 and f2 confirm the inner structure (PVP-5-
FU) has dissolved, resulting in hollow fibrous structures. Moreover, some fibers 
possessed several hollowed sections (Fig. 2f1, labeled with green arrow) which may be 
due to the synergistic effects of phase segregation and disturbance of roller during CO-
ES process. 
 
3.2. FT-IR analysis of core-shell nanofibers 
  FT-IR spectra of CS, 5-FU, and resulting fibers are shown in Fig. 3a. The peaks at 
around 2949 and 1729 cm-1 was the vibration of C=O and CH2 respectively, in PCL 
(Wang et al., 2016); with the CH2 twisting, C=O vibration, CH2 stretching being 
responsible for the absorption peaks appearing at 1288, 1654, and 2954 cm-1, 
respectively (Wu et al., 2018). Characteristic peaks of CS can be seen at 872 cm-1 and 
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broad peaks arising at 3423 cm−1 region are due to β-(1,4) glycosidic vibrations of O-
H and N-H, respectively (Yue et al., 2009). The peaks showed at 1556 cm-1 and 1656 
cm-1 region were the vibration of amide II band and amide I band respectively 
(Kucukgulmez et al., 2011; Rinaudo, 2006) and the hydrogen bond between N-H and 
C=O group was highlighted at 1656 cm-1 (Kucukgulmez et al., 2011).  
The absorption peaks around 3067, 2939 and 2828 cm-1 in the spectra of pure 5-FU 
are attributed to aromatic and aliphatic C-H vibration (Kevadiya et al., 2012); and the 
CO-NH-CO, amide I and amide III (C=O) peaks found at 1725, 1672, and 1247 cm-1, 
respectively (Lin et al., 2002). The vibration of C-H located in-plane and out-of-plane 
of CF=CH showed peaks at 1426 and 814 cm-1, respectively (Kevadiya et al., 2012). 
When comparing the spectra of resulting fibers loaded with 5-FU and CS of various 
concentration, these characteristic peaks of CS and 5-FU can be seen in all cases with 
slight shifts in wavelength, indicating CS and 5-FU were not only attached on the 
surface but also existed within the fibers by the formation of chemical bonds (i.e. 
hydrogen bonds) (Nazari et al., 2017). 
 
3.3. XRD analysis of core-shell nanofibers 
  The powder XRD analysis was used to reveal the changes in physical state of drugs 
and fibers during CO-ES process. As shown in Fig. 3b, the pristine PCL, the sharp 
diffraction peak at 2θ = 22.2° was attributed to the diffraction of lattice plane (200) 
(Meng et al., 2010). The XRD spectrum of PVP showed two broad diffraction peaks at 
2θ = 11.3°, 21.0°, indicating amorphous PVP was helpful for drug delivery (Wu et al., 
2018). In the spectrum of 5-FU powder, the diffraction peaks at 2θ = 16.1°, 
18.8°,19.9°,21.7°,28.4°,31.9°, and 33.0° are consistent with the results showed in 
previous work (Li et al., 2011); and demonstrate the 5-FU powder existed in the 
crystalline state. The diffraction peaks of CS appeared at 2θ = 6.2°, 10.2°, 20.1°, 30.1°, 
35.2°, 38.0°; and the peak at 2θ = 20.1° was due to diffraction of plane (020, 110) 
(Lavall et al., 2007).  
The diffraction peaks for PCL/PVP appeared at 2θ =21.1°, 24.1°. While comparing 
with the pure PCL powder, the intensity of the diffraction peaks for PCL/PVP blending 
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fibers had decreased, which may be attributed to the slowed crystallization of PCL 
during CO-ES process (Meng et al., 2010). Besides, the differences between the XRD 
spectrum between PCL-CS/PVP-5-FU and PCL/PVP were obvious: two sharp 
diffraction peaks overlaid with a broad peak appeared at 2θ =20.9°, 24.0°. This 
probably resulted from the vibration of CS attached on the PCL surface, and 
demonstrating the content of CS and 5-FU can influence the crystallization and crystal 
type of PCL-CS/PVP-5-FU blending fibers. 
 
3.4. Surface hydrophilicity  
The hydrophilicity of film influences drug release and is crucial for bio-related 
applications (Wang et al., 2018). Here, water contact angle (CA) of resulting fibers was 
measured to reveal the effects of CS or 5-FU concentration on fibrous hydrophilicity. 
The results are shown in Fig. 4. The initial CA (θ, the CA at the moment that water drop 
contacts fibers surface) of F-1, F-2, F-3, F-4, and F-5 films were 114.4, 90.1, 84.2, 73.1, 
and 71.8°, respectively. The results indicate F-1 and F-2 films are hydrophobic, while 
the F-3, F-4 and F-5 films were hydrophilic. The increase in CS concentration in PCL 
improved hydrophilicity of the films. Moreover, the CA value (θ) of the electrospun 
films was examined over a period of 240 s as shown in Fig. 4b. The final CA of F-1, F-
2, F-3, F-4, and F-5 films were 101.4, 61.1, 18.6, 0, and 0°, respectively. As shown in 
Fig. S2, the change of CA over time was not constant, a steep decline followed slowly 
decreasing. The final CA decreased to 0° in 8 s for F-4, and 3 s for F-5. The results the 
more CS there is present in the fibers, the fast the diffusion of water through the fibers. 
This may be due to that the surface morphology of fiber was rougher when the content 
of CS was higher (shown with the SEM images in Fig. 2). As CS concentration 
increased, the gap between two fibers increased which was conducive to flow of 
medium. Therefore, addition with CS can broaden the application of hydrophobic 
agents.  
 
3.5. Mechanical properties  
Under tensile stress, the film was stretched and elongated as shown in Fig. 5a. Once 
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a specified distance between two clampers for test sample is reached, tensile stress can 
be recorded at various stages (Fig. S3). Fig. 5b shows tensile curves for different 
samples and reveals each sample possessed ductile failure characteristics (Shi et al., 
2018). The maximum tensile strain decreased as the CS content increased; decreasing 
from 332% for F-1 to 33.7% for F-5. Besides, the maximum tensile stress decreased 
with increase of CS content, except for F-3 composite films. The maximum tensile 
stresses of simple F-1 and F-5 composite films were 33.2 MPa and 4.8 MPa, 
respectively. The addition of ingredients content minimized the mechanical properties 
of composite films, which is consistent with the results showed in previous work (Wang 
et al., 2016). This is attributed to the changes of composite films microstructure 
resulting from addition of CS and 5-FU. When PCL/PVP composite fiber encapsulated 
CS and 5-FU, the polymer matrix molecular chains were likely to be discontinuous and 
uneven; resulting in rough surfaces (see Fig. 2 SEM images). Enlarging the gap between 
fibers would result in low tensile strength. However, the membranes presented good 
mechanical property without rupturing. 
 
3.6. In-vitro release of CS and 5-FU  
The CO-ES process has showed effective and economic superiority for loading 
capacity (LC) and encapsulation efficiency (EE) of ingredients (Wang et al., 2018). 
Here, the effect of CS content on the LC and EE was examined. When CS content 
increased from 2wt% to 8wt%, LC of 5-FU ranged from 0.43±0.01% to 0.48 ± 0.02%, 
and EE of 5-FU increased from 87.7 ± 3.1% to 97.7 ± 3.4% (Fig. 6a). The influence of 
CS content on the LC and EE was not obvious, which due to the 5-FU content was 
constant (2wt%) and was encapsulated in core layer. However, higher content of CS 
improved LC and EE. The LC increased from 3.19 ± 0.14% to 14.1 ± 0.66%, while EE 
was in the range of 90.4 ± 0.4% and 94 ± 0.7%, when CS content was increased from 
2wt% to 8wt%, as shown in Fig. 6b. 
  To mimic the general micro-environment of melanoma cells, the releases of 
composite films were performed in PBS (pH = 5.7 ± 0.1) (Sahu et al., 2017; Wang et 
al., 2018). As results show in Fig. S4a & b, nearly 60% and 89% of CS and 5-FU was 
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released within the first 10 h, respectively. The higher content of CS improved the 
release of CS and 5-FU, except for the release of CS and 5-FU from F-3 films. The 
rapid dissolution of the PVP core layer resulted in the “burst” release of 5-FU. The 
rapid release of CS was due to the faintly acid micro-environment (pH = 5.7 ± 0.1) 
which improves the solubility of CS (Pillai et al., 2009). Moreover, CS was loaded in 
outer shell layer, thus the difference between the cumulative release of CS and 5-FU 
was less significant than in theory.  
In vitro results of drug release indicate that ~78% of CS and 91% of 5-FU were 
released within 24 h, respectively (Fig. 6c). The burst release characteristic of 5-FU and 
sustained release of CS was revealed within the first 120 min (Fig. 6d). Nearly 87% of 
5-FU was released from F-5 and approximate 40% of CS was released within 120 min. 
This offers a desirable anticancer property with minimum adverse effects. In addition, 
to quantify the CS/5-FU release mechanisms, the in-vitro release data was fitted to 
Korsmeyer-Peppas model and first order model (Dash et al., 2010). As seen in Table 2, 
both high correlation coefficients (R2) were obtained from the Korsmeyer-Peppas 
model (Fig. S4 c-f). The n value for CS and 5-FU was 0.3881 and 0.2489, respectively. 
This indicates the release of CS and 5-FU were dominated mainly by Fickian diffusion 
mainly (n＜0.45).  
 
3.7. Evaluation of anticancer effect  
The effect of 5-FU on L929 (fibroblast cell) and B16F10 (mouse melanoma cell) 
proliferation were assessed using CCK-8 method. As shown in Fig. 7 a & b, the cell 
viability of L929 and B16F10 were significantly decreased upon 5-FU treatment in a 
dose-dependent manner. This confirmed the inhibitory effects of 5-FU on melanoma 
cells (B16F10 cells) and unavoidable negative effect on normal skin cells (L929 cells). 
Thus, restoring efficacy by using CS to compensate the adverse effects of 5-FU on 
normal cells is needed in practice. Compared to the 5-FU treatment group, the decrease 
of cell viability for negative group (DMSO) was less obvious, which indicates the side-
effect of solvent (DMSO) was negligible and the inhibitory effect resulted mainly from 
5-FU. 
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3.7.1. Anticancer effect on melanoma cell (B16F10) 
The ability of the engineered films to induce apoptosis in B16F10 cells was 
investigated using flow cytometry analysis. As shown in Fig. 8a, b1&b2, the proportion 
of early apoptosis stage cells (quadrant 4th: lower right) and late apoptosis stage cells 
(quadrant 1st: upper right) evidently increased upon treatment of F-5 composite sample 
in time-dependent manner when compared to the blank control group (Fig. 8a). The 
proportion of quadrant 1 cells increased from 0.8% (Fig. S5a i) to 20.7% and 62.2% 
after being treatment for 8 h (Fig. S5a ii) and 24 h (Fig. S5a iii), respectively. The 
proportion of quadrant 4 cells increased from 0.1% (Fig. S5a i) to 14.5% and 12.8% 
after being treatment 8 h (Fig. S5a ii) and 24 h (Fig. S5a iii), respectively. These results 
indicate that the F-5 composite sample inhibited the proliferation of B16F10 cells and 
induced apoptosis in a time-dependent manner.  
The effects of F-5 films on cell cycle of B16F10 was determined using flow 
cytometry analysis (Fig. 8a’, b1’& b2’). As shown in Fig. 8c, the ratio of B16F10 cells 
in G0/G1 phase decreased slightly upon treatment with F-5 composite films (64.8 ± 0.7% 
for 8 h, and 64.4 ± 0.5% for 24 h) comparing with blank control (65.8 ± 1.4%). The 
proportion of cells in S and G2/M phases were influenced by blending films obviously. 
The proportion of cells in S and G2/M phases for control group was 20.6± 0.3% and 
7.9 ± 1.0%, respectively. After being treated for 8 h, the proportion of cells in the two 
phases was 22.1 ± 0.3% and 5.4 ± 0.4%, respectively. When the treatment time prolong 
to 24 h, the proportion of cells in the two phases was 14.5 ± 1.5% and 12.1 ± 1.6%, 
respectively. 
	
3.7.2. Synergetic effect on fibroblast cell (L929 cell) 
For the L929 cells, the proportion of quadrant 3rd cells (vital cells) (lower left 
quadrant) for treatment groups (Fig. 9b1-c2) were smaller than that of blank control 
group (Fig. 8a), which demonstrates the adverse effect of 5-FU treatment on L929 cells 
(normal skin cells). The pie chart results (Fig. S5b) offered precise results with the vital 
cells of treatment groups being smaller than that of blank control group (82.47%). 
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Moreover, the difference between the treatment of blending fibrous film without CS 
(Fig. 8b1 & c1) and with CS (Fig. 8b2 & c2) were significant. The proportion of 
quadrants 1st, 3rd, and 4th cells number were evidently influenced by the CS. As shown 
in the pie chart, the proportion of quadrant 3rd cells increased from 47.95% to 78.83%, 
after being treated with F-0 (Fig. S6b ii) and F-5 (Fig. S6b iii) blending films for 8 h. 
The early apoptosis stage cells decreased from 22.67% to 8.85%. These results show 
CS can enhance the vital cells number and reduce apoptosis cells number. These results 
confirmed the “remedying” effects of CS on L929 cells suffered adverse effects from 
5-FU by accident. 
Fig. 8b1’ to c2’ show that the ratio of L929 cells in G0/G1 and S phases was 
influenced by the blended films; both with and without CS. For the control group, the 
ratio of L929 cells in G0/G1 and S phases was 73.39 ± 0.61% and 10.77 ± 0.33%, 
respectively. After being treatment for 8 h, the ratio of cells in G0/G1 and S phases was 
52.23 ± 1.42% and 37.47 ± 0.85% for the F-5 films, and 70.3 ± 1.1% and 17.54 ± 0.65% 
for the F-0 films. The effects of decreased cells proportion in G0/G1 and increased cells 
proportion in S phase effects were also revealed CS following 24 h of treatment with 
films with and without CS.  
 
3.8. AO/EB staining 
AO/EB dual fluorescent staining was used to visualize the inhibitory effect and 
“remedying” effect of F-5 composite films on B16F10 and L929 cells, respectively. As 
the results show in Fig. 10, the cells were divided into four types using these two DNA 
dyes, where vital cells (green), early apoptosis cells (green with orange spots), late 
apoptosis cells (green with orange area), necrotic cells (red) (Kamel et al., 2017). As 
shown in Fig. 10a & b, all the cells exhibited green fluorescence, which indicates the 
PCL/PVP blending films (Fig. 10b) do not have side-effects on B16F10 cells (Fig. 10a). 
The proportion of apoptosis and necrotic cells in treatment groups (Fig. 10c1- c2) were 
varied when compared to the control (Fig. 10a), demonstrating the anticancer effects of 
5-FU loaded blending films against B16F10 cells.  
Meanwhile, the proportion of apoptosis and necrotic cells following treatment with 
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CS and 5-FU loaded blending films (Fig. 10c2) were less than that for blending films 
loaded with 5-FU only (Fig. 10c1), which may be attributed to the proliferation 
promotion nature of CS (Zhu et al., 2019). For the L929 cells, the green fluorescence 
with the control (Fig. 10a') and negative control (Fig. 10b’) do not show any obvious 
differences, which indicates the PCL/PVP blending films do not have side-effects on 
L929 cells. Moreover, the proportion of apoptosis and necrotic cells in treatment of 
blending films encapsulating 5-FU only for 8 h (Fig. S8a) were decreased in the 
treatment of films encapsulating CS and 5-FU at the same time (Fig. S8b). These results 
confirmed the “remedying” effects of CS on L929 cells suffered adverse effects from 
5-FU by accident. Thus, the “remedying” effects of composite films on L929 cells were 
confirmed, and may be obtained from “rescuing” early apoptosis cells.   
 
4. Conclusion 
In this work, a novel core-shell nanofiber drug delivery system for skin melanoma 
was investigated. Core-shell structure PCL/PVP composite nanofiber loading CS 
(chitosan) and 5-FU (5-Fluorouracial) into shell layer and core layer, respectively. The 
PCL-CS/PVP-5-FU fibers had an average diameter of ~503 nm and presented high 
drug-encapsulating efficiency, and good mechanical properties. Moreover, the 
proposed films showed significant inhibitory proliferation effects on B16F10 cells in-
vitro through arresting cell cycle progression at S phase and G2/M phase in time-
dependent manner. More importantly, the composite films possessed the “remedying” 
ability to compensate the adverse effect of L929 cells suffered from 5-FU may through 
increasing cell cycle progression at G0/G1 phase and S phase mainly. It is expected that 
an effective therapeutic for melanoma possessing minimum adverse effects of 5-FU on 
normal cells will be realized in future clinical trials in this way.  
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Figure Captions 
Fig. 1. Schematic diagram of coaxial-electrospinning setup (a); the effect of voltage on 
the forming process of continuous stable-jet mode (b), i-vi: 0-17.5 kV; and 3D structural 
molecule model of 5-FU (c1), PVP monomer (c2), CS (c3), and PCL monomer (c4). 
Fig. 2. Optical micrographs, scanning electron micrographs, and mean diameter 
distribution of electrospun fibers loading various concentration of CS and 5-FU: a1-a3, 
F-1; b1-b3, F-2; c1-c3, F-3; d1-d3, F-4; e1-e3, F-5; f1, scanning electron micrographs 
of F-5 fibers following in vitro release studies, and f2 was the higher magnification of 
fiber labeled red arrow in f1. 
Fig. 3. FT-IR spectra (a), and XRD spectra (b) of blending fibers, and pristine materials: 
CS, 5-FU, PCL, PVP.	
Fig. 4. Water contact angle images of fibrous films at various time point: 0 s and 240 s 
(a); the value of θ in Fig. 4a expressed with column chart (b). *p<0.05, **p<0.01, N.S.: 
not significant, n=3. 
Fig. 5. Optical image of fibrous film (F-1) during tension testing process (a); stress-
strain curves of fibrous films loading various concentration of CS and 5-FU (b). 
Fig. 6. The loading capacity and encapsulate efficiency of 5-FU (a) and CS (b) of 
electrospun fibers:  F-2, F-3, F-4, F-5 films; and accumulate release of CS and 5-FU 
of F-5 films in PBS (pH = 5.7 ± 0.1) within 140 h (c), and first 120 min (d). 
Fig. 7. The effects of 5-FU on cell viability of L929 cells (a) and B16F10 cells (b): 0 
mg/mL, blank control; N., negative control (10 µL DMSO added into 90 µL MEM).  
Fig. 8. Flow cytometry analysis on apoptosis and cell cycle of B16F10 cells. a, b1, and 
b2 are apoptosis results of B16F10 cells treated with blank control, F-5 sample for 8 h, 
and F-5 sample for 24 h, respectively;	 a’, b1’, and b2’ are cell cycle results 
corresponding to treatment of a, b1, b2, respectively; c: the cell cycle results of control 
(a’), 1 (b1’), 2 (b2’) expressed as column chart.	
Fig. 9. Flow cytometry analysis on apoptosis and cell cycle of L929 cell. a, b1, b2, c1, 
and c2: are apoptosis results of L929 cells treated with blank control, F-0 films for 8 h, 
F-5 films for 8 h, F-0 for 24 h, and F-5 films for 24 h, respectively; a’, b1’, b2’, c1’, c2’ 
are cell cycle results corresponding to treatment of a, b1, b2, c1, and c2, respectively; 
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d: the cell cycle results expressed as column chart (control, 1, 2, 3, 4 corresponding to 
a’, b1’, b2’, c1’, c2’).	
Fig. 10. Fluorescent images of B16F10 and L929 cells stained with AO/EB dye: a, b, 
c1, c2: merging fluorescent images of B16F10 cells treated with blank control, F-1 films 
for 24 h, F-5 films for 8 h, and F-5 films for 24 h, respectively; a’, b’, c1’, c2’: merging 
fluorescent images of L929 cells treated with blank control, F-1 films for 24 h, and F-
0 films for 24 h, F-5 films for 24 h, respectively. 
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Tables and Figures 
Table 1  
The solution of CO-ES. 
 
 
Fiber 
Fiber composition 
core shell 
wt% of PVP in 
the core 
wt% of 5-FU in 
the core 
wt% of PCL in 
the shell 
wt% of CS in the 
shell 
F-0 98 2 100 0 
F-1 100 0 100 0 
F-2 98 2 98 2 
F-3 98 2 96 4 
F-4 98 2 94 6 
F-5 98 2 92 8 
 
Table 2 
Korsmeyer-Peppas model applied to release kinetics of CS and 5-FU. 
  
 
 
 
 
 
 
 
  
Films  Agent Korsmeyer-Peppas model k n R2 
F-5 CS log10(Mt/M∞) = 0.3881log10(t)+1.4918 6979.99 0.3881 0.9138 
F-5 5-FU log10(Mt/M∞) = 0.2489log10(t)+1.9339 5.89×107 0.2489 0.9268 
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Fig. 2. 
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Fig. 3. 
 
 
Fig. 4. 
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Fig. 5. 
 
 
 
 
Fig. 6. 
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Fig. 8. 
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Fig. 9. 
 
 
 
Fig. 10. 
